adenocarcinoma
Showing NaN - NaN of 8
RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide
Active, not recruiting
- RET-altered Non Small Cell Lung Cancer
- +39 more
- pralsetinib (BLU-667)
-
Phoenix, Arizona
- +65 more
Nov 10, 2022
Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)
Recruiting
- Neuroendocrine Tumor
- +4 more
- Cabozantinib 40 mg
-
Badalona, Barcelona, Spain
- +14 more
Feb 15, 2022
NSCLC, NSCLC, Adenocarcinoma Trial in Worldwide (MM-121, Docetaxel)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
-
Tucson, Arizona
- +34 more
Oct 11, 2021
Adenocarcinoma Trial in Fuenlabrada, Madrid, Zaragoza (Personalised treatment, Treatment chosen per investigator´s judge)
Unknown status
- Adenocarcinoma
- Personalised treatment
- Treatment chosen per investigator´s judge
-
Fuenlabrada, Madrid, Spain
- +4 more
Feb 24, 2021
Gastric Cancer, Adenocarcinoma Trial in Worldwide (biological, drug, other)
Completed
- Gastric Cancer
- Adenocarcinoma
- ramucirumab
- +2 more
-
Bakersfield, California
- +160 more
Sep 10, 2019
Lung Cancer, Adenocarcinoma, NSCLC Trial in Germany, Spain, Switzerland (Crizotinib)
Unknown status
- Lung Cancer
- +2 more
-
Heidelberg, Baden-Würtemberg, Germany
- +17 more
Jul 11, 2019
Carcinoma, Adenocarcinoma, Renal Cell Trial in Worldwide (RAD001(everolimus), interferon alfa-2a, bevacizumab)
Completed
- Carcinoma
- +4 more
- RAD001(everolimus)
- +2 more
-
Fayetteville, Arkansas
- +107 more
Feb 13, 2017
